Trauma Management in a War Zone: The Lebanese War Experience von NASSOURA, ZAHI, HAJJ, HANI, DAJANI, OMAR, JABBOUR, NICHOLAS, ISMAIL, MOUSTAFA, TARAZI, TONI, KHOURY, GHATTAS, NAJJAR, FAYSAL

Volltext

Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial von Atkins, Michael B, Plimack, Elizabeth R, Puzanov, Igor, Fishman, Mayer N, McDermott, David F, Cho, Daniel C, Vaishampayan, Ulka, George, Saby, Olencki, Thomas E, Tarazi, Jamal C, Rosbrook, Brad, Fernandez, Kathrine C, Lechuga, Mariajose, Choueiri, Toni K

Volltext

Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial von Atkins, Michael B., Plimack, Elizabeth R., Puzanov, Igor, Fishman, Mayer N., McDermott, David F., Cho, Daniel C., Vaishampayan, Ulka, George, Saby, Tarazi, Jamal C., Duggan, William, Perini, Rodolfo, Thakur, Mahgull, Fernandez, Kathrine C., Choueiri, Toni K.

Volltext

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma von Martini, Jean-Fran Comma Cois, Plimack, Elizabeth R., Choueiri, Toni K., McDermott, David F., Puzanov, Igor, Fishman, Mayer N., Cho, Daniel C., Vaishampayan, Ulka, Rosbrook, Bradley, Fernandez, Kathrine C., Tarazi, Jamal C., George, Saby, Atkins, Michael B.

Volltext

Abstract CT093: Axitinib in combination with pembrolizumab (AXI+PEMBRO) in patients (pts) with advanced renal cell carcinoma (aRCC): Analysis of immune-related biomarkers von Atkins, Michael, Martini, Jean-Francois, Plimack, Elizabeth, McDermott, David, Puzanov, Igor, Fishman, Mayer, Cho, Daniel, Vaishampayan, Ulka, Rosbrook, Brad, Fernandez, Kathrine, Tarazi, Jamal, George, Saby, Choueiri, Toni

Volltext

Axitinib plus pembrolizumab in patients with advanced renal cell carcinoma: Long-term efficacy and safety from a phase Ib study von Atkins, Michael B., Puzanov, Igor, Plimack, Elizabeth R., Fishman, Mayer N., McDermott, David F., Cho, Daniel C., Vaishampayan, Ulka N., George, Saby, Tarazi, Jamal Christo, Duggan, William, Perini, Rodolfo F., Fernandez, Kathrine C., Choueiri, Toni K.

Volltext

Safety and efficacy of axitinib (axi) in combination with pembrolizumab (pembro) in patients (pts) with advanced renal cell cancer (aRCC) von Atkins, Michael B., Plimack, Elizabeth R., Puzanov, Igor, Fishman, Mayer N., McDermott, David F., Cho, Daniel C., Vaishampayan, Ulka N., George, Saby, Olencki, Thomas, Tarazi, Jamal Christo, Rosbrook, Brad, Fernandez, Kathrine C., Lechuga, Mariajose, Choueiri, Toni K.

Volltext

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma von Atkins, Michael B, Gupta, Shilpa, Choueiri, Toni K, McDermott, David F, Puzanov, Igor, Tarazi, Jamal, Keefe, Stephen, Rosbrook, Brad, Chakrabarti, Debasis, Plimack, Elizabeth R

Volltext